Seco-tanapartholide B - Compound Card

Seco-tanapartholide B

Select a section from the left sidebar

Seco-tanapartholide B

Structure
Zoomed Structure
  • Family: Plantae - Asteraceae
  • Kingdom: Plantae
  • Class: Lignan
Canonical Smiles CC(=O)C[C@@H]1C(=C)C(=O)O[C@@H]1[C@@H]1[C@@H](O)C=CC1=O
InChI InChI=1S/C13H14O5/c1-6(14)5-8-7(2)13(17)18-12(8)11-9(15)3-4-10(11)16/h3-4,8-9,11-12,15H,2,5H2,1H3/t8-,9+,11-,12+/m1/s1
InChIKey NLIIVDIRTOEQOC-DMWPJOQESA-N
Formula C13H14O5
HBA 5
HBD 1
MW 250.25
Rotatable Bonds 3
TPSA 80.67
LogP 0.18
Number Rings 2
Number Aromatic Rings 0
Heavy Atom Count 18
Formal Charge 0
Fraction CSP3 0.46
Exact Mass 250.08
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Pentzia monodiana Asteraceae Plantae 301874

Showing of synonyms

  • Ortiz S, Dali-Yahia K, et al. (2017). Heme-binding activity of methoxyflavones from Pentzia monodiana Maire (Asteraceae). Natural product research,2017, 31(11), 1325-1328. [View] [PubMed]
Pubchem: 101254615
Nmrshiftdb2: 60058310

No compound-protein relationship available.

Structure

SMILES: C=C1C(=O)OC(C1)C2CC=CC2=O

Level: 1

Mol. Weight: 250.25 g/mol

Structure

SMILES: C=C1C(=O)OCC1

Level: 0

Mol. Weight: 250.25 g/mol

Structure

SMILES: O=C1C=CCC1

Level: 0

Mol. Weight: 250.25 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.77
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.72
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.82

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.55
Plasma Protein Binding
38.13
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
5.18
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.69
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.82
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
4.47
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Toxic
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
0.46
Rat (Acute)
3.44
Rat (Chronic Oral)
2.12
Fathead Minnow
3.93
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Toxic

General Properties

Boiling Point
342.36
Hydration Free Energy
-11.4
Log(D) at pH=7.4
-0.31
Log(P)
-0.71
Log S
-1.65
Log(Vapor Pressure)
-7.13
Melting Point
181.3
pKa Acid
5.3
pKa Basic
4.79
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Xylose isomerase P24300 XYLA_STRRU Streptomyces rubiginosus 3 0.9191
Serpin domain-containing protein H0ZQY2 H0ZQY2_TAEGU Taeniopygia guttata 3 0.8409
Carbonic anhydrase 1 P00915 CAH1_HUMAN Homo sapiens 3 0.8105
Putative b-glycan phosphorylase Q21MB1 Q21MB1_SACD2 Saccharophagus degradans 3 0.7015

Download SDF